Literature DB >> 15870293

The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation.

Sravan K Goparaju1, Puneet S Jolly, Kenneth R Watterson, Meryem Bektas, Sergio Alvarez, Sukumar Sarkar, Lin Mel, Isao Ishii, Jerold Chun, Sheldon Milstien, Sarah Spiegel.   

Abstract

Sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, is the ligand for five specific G protein-coupled receptors, named S1P(1) to S1P(5). In this study, we found that cross-communication between platelet-derived growth factor receptor and S1P(2) serves as a negative damper of PDGF functions. Deletion of the S1P(2) receptor dramatically increased migration of mouse embryonic fibroblasts toward S1P, serum, and PDGF but not fibronectin. This enhanced migration was dependent on expression of S1P(1) and sphingosine kinase 1 (SphK1), the enzyme that produces S1P, as revealed by downregulation of their expression with antisense RNA and small interfering RNA, respectively. Although S1P(2) deletion had no significant effect on tyrosine phosphorylation of the PDGF receptors or activation of extracellular signal-regulated kinase 1/2 or Akt induced by PDGF, it reduced sustained PDGF-dependent p38 phosphorylation and markedly enhanced Rac activation. Surprisingly, S1P(2)-null cells not only exhibited enhanced proliferation but also markedly increased SphK1 expression and activity. Conversely, reintroduction of S1P(2) reduced DNA synthesis and expression of SphK1. Thus, S1P(2) serves as a negative regulator of PDGF-induced migration and proliferation as well as SphK1 expression. Our results suggest that a complex interplay between PDGFR and S1P receptors determines their functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870293      PMCID: PMC1087716          DOI: 10.1128/MCB.25.10.4237-4249.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy.

Authors:  Y Morita; G I Perez; F Paris; S R Miranda; D Ehleiter; A Haimovitz-Friedman; Z Fuks; Z Xie; J C Reed; E H Schuchman; R N Kolesnick; J L Tilly
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

Review 2.  Lysophospholipid G protein-coupled receptors.

Authors:  Brigitte Anliker; Jerold Chun
Journal:  J Biol Chem       Date:  2004-03-15       Impact factor: 5.157

3.  Gab1 contributes to cytoskeletal reorganization and chemotaxis in response to platelet-derived growth factor.

Authors:  Anders Kallin; Jean-Baptiste Demoulin; Keigo Nishida; Toshio Hirano; Lars Rönnstrand; Carl-Henrik Heldin
Journal:  J Biol Chem       Date:  2004-02-17       Impact factor: 5.157

4.  Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis.

Authors:  D English; A T Kovala; Z Welch; K A Harvey; R A Siddiqui; D N Brindley; J G Garcia
Journal:  J Hematother Stem Cell Res       Date:  1999-12

5.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

Authors:  Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

6.  Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens.

Authors:  A Olivera; S Spiegel
Journal:  Nature       Date:  1993-10-07       Impact factor: 49.962

7.  Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice.

Authors:  P Soriano
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

8.  Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities.

Authors:  P Levéen; M Pekny; S Gebre-Medhin; B Swolin; E Larsson; C Betsholtz
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

9.  Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells.

Authors:  Tatsuo Tanimoto; Andreea O Lungu; Bradford C Berk
Journal:  Circ Res       Date:  2004-03-25       Impact factor: 17.367

10.  Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53.

Authors:  Tarek A Taha; Walid Osta; Lina Kozhaya; Jacek Bielawski; Korey R Johnson; William E Gillanders; Ghassan S Dbaibo; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2004-02-26       Impact factor: 5.157

View more
  58 in total

Review 1.  Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.

Authors:  Roger A Sabbadini
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

2.  FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells.

Authors:  Yaxian Kong; Hong Wang; Shuling Wang; Na Tang
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

Review 3.  Outside the box signaling: secreted factors modulate GnRH receptor-mediated gonadotropin regulation.

Authors:  Hanna Pincas; Soon Gang Choi; Qian Wang; Jingjing Jia; Judith L Turgeon; Stuart C Sealfon
Journal:  Mol Cell Endocrinol       Date:  2013-08-28       Impact factor: 4.102

Review 4.  Regulation of vascular physiology and pathology by the S1P2 receptor subtype.

Authors:  Athanasia Skoura; Timothy Hla
Journal:  Cardiovasc Res       Date:  2009-03-15       Impact factor: 10.787

5.  Sphingosine 1-phosphate-mediated α1B-adrenoceptor desensitization and phosphorylation. Direct and paracrine/autocrine actions.

Authors:  Jean A Castillo-Badillo; Tzindilú Molina-Muñoz; M Teresa Romero-Ávila; Aleida Vázquez-Macías; Richard Rivera; Jerold Chun; J Adolfo García-Sáinz
Journal:  Biochim Biophys Acta       Date:  2011-10-13

6.  Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.

Authors:  Barry S Shea; Sarah F Brooks; Benjamin A Fontaine; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

7.  Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2.

Authors:  Hitoshi Ikeda; Naoko Watanabe; Isao Ishii; Tatsuo Shimosawa; Yukio Kume; Tomoaki Tomiya; Yukiko Inoue; Takako Nishikawa; Natsuko Ohtomo; Yasushi Tanoue; Satoko Iitsuka; Ryoto Fujita; Masao Omata; Jerold Chun; Yutaka Yatomi
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

Review 8.  Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling.

Authors:  Deborah A Lebman; Sarah Spiegel
Journal:  J Lipid Res       Date:  2008-04-02       Impact factor: 5.922

9.  Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype.

Authors:  Susann Fayyaz; Janin Henkel; Lukasz Japtok; Stephanie Krämer; Georg Damm; Daniel Seehofer; Gerhard P Püschel; Burkhard Kleuser
Journal:  Diabetologia       Date:  2013-11-29       Impact factor: 10.122

10.  S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses.

Authors:  Christopher Kable Means; Shigeki Miyamoto; Jerold Chun; Joan Heller Brown
Journal:  J Biol Chem       Date:  2008-02-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.